The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 26, 2017

Filed:

Jun. 12, 2014
Applicant:

Surmodics, Inc., Eden Prairie, MN (US);

Inventors:

Joram Slager, Saint Louis Park, MN (US);

Aleksey V. Kurdyumov, Lino Lakes, MN (US);

Toni M. Heyer, Saint Louis Park, MN (US);

Assignee:

SURMODICS, INC., Eden Prairie, MN (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61F 2/00 (2006.01); A61L 29/16 (2006.01); C07D 498/18 (2006.01); A61K 9/14 (2006.01); A61K 31/436 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61L 29/16 (2013.01); A61K 9/14 (2013.01); A61K 31/436 (2013.01); C07D 498/18 (2013.01); A61K 9/0019 (2013.01); A61L 2300/416 (2013.01); Y10T 428/2982 (2015.01);
Abstract

The invention provides therapeutic particulates including a macrolide, such as rapamycin, in solid state crystalline form, having a size of 20μm or less, or 10μm or less. The particulates are formed in one method by preparing a composition with a macrolide and first (e.g., xylene) and second (e.g., an alcohol, acetone, or acetonitrile) solvents. In the composition a maximum solubility for the macrolide that is greater than a maximum solubility of the macrolide dissolved in either the first or second solvent individually. The first and second solvents are then evaporated from the composition to provide the macrolide particulates. In another method, the particulates can be formed by a method including sonication and stirring/evaporation steps, and the particulates can be obtained from a supersaturated solution, formed during the process. Particulates display desirable low polydispersity, and can be used in therapeutic compositions, or can be associated with an implantable or insertable medical device for the treatment of a subject.


Find Patent Forward Citations

Loading…